3DelgadoJ,Jimenez-Yuste V, Hernandez-Navarro F, et al. Acquired haemophilia: review and meta-analysis focused on therapy and prognostic factorsjf], BrJ Haematol, 2003,121(1): 21-35.
4Shetty S, Bhave M, Ghosh K. Acquired hemophilia A: diagnosis, aetiology, clinical spectrum and treatment options[J]. Autoimmun Rev, 2011,10(6): 311-316.
5Franchini M. Acquired hemophilia A[J]. Hematology, 2006, 11(2): 119-125.
6Toschi V, Baudo F. Diagnosis, laboratory aspects and management of acquired hemophilia A[J]. Intem Emerg Med, 2010, 5(4): 325-333.
7Collins P, Baudo F, Knoebl P, et al. Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2)[J]. Blood, 2012,120(1): 47-55.
8Collins PW, Hirsch S, Baglin TP, et al. Acquired hemophilia A in the United Kingdom: a 2-year National surveillance study by the United Kingdom Haemophilia Centre Doctors' Organisation[J]. Blood, 2007,109(5): 1870-1877.
9Franchini M, Targher G, Manzato F, et al. Acquired factor vm inhibitors in oncohematology: a systematic review[J]. Crit Rev Oncol Hematol, 2008, 66(3): 194-199.
10Aouba A, Rey G, Pavillon G, et al. Deaths associated with acquired haemophilia in France from 2000 to 2009: multiple cause analysis for best care strategies[J]. Haemophilia, 2012, 18(3): 339-344.
